By Elizabeth L. Ciemins, PhD, MA, Carlos A. Moreno, MPH, and Jeff Mohl, PhD

Colorectal cancer (CRC) is the third leading cause of cancer death in the U.S., and estimates suggest there will be approximately 53,000 deaths attributed to the disease in 2023. When found early, CRC is one of the most treatable forms of cancer, but the survival rate plummets with diagnosis at late stages. AMGA is leading efforts to improve CRC screening completion with a new testing measure.

Published Group Practice Journal, March/April 2023. ©AMGA

Share this Article: